Usually, the condition of patients with blood uric acid 517μmol/L alone is relatively mild. If the patient’s blood uric acid 517μmol/L is combined with gout, gouty nephropathy and other comorbidities, or the presence of hypertension, diabetes mellitus and other metabolic syndromes, the condition is relatively more serious.
Blood uric acid 517μmol/L is higher than normal, and hyperuricemia can be diagnosed if the patient’s fasting blood uric acid is greater than 420μmol/L on two occasions not on the same day. Some patients with hyperuricemia may live their entire lives without developing comorbidities such as gouty attacks, gouty stones, gouty nephropathy, etc., i.e., asymptomatic hyperuricemia, and the condition is usually relatively mild.
If patients have the above comorbidities, or if they also have manifestations of metabolic syndrome such as hypertension, diabetes mellitus, hyperlipidemia, atherosclerosis, etc., which have a greater impact on the patient’s multiple organ functions and seriously affect the quality of life, the condition is relatively more severe.
It is recommended that patients with blood uric acid 517μmol/L should go to the rheumatology and immunology department of the hospital in time and receive standardized treatment under the guidance of the doctor, so as not to delay the condition.